Skip to content

Study of Tai Chi Exercise and Balance in Persons With Parkinson's Disease

Phase II Study of Tai Chi Exercise in Relation to Balance in Persons With Parkinson's Disease

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00611481
Enrollment
195
Registered
2008-02-11
Start date
2008-10-31
Completion date
2011-08-31
Last updated
2011-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Brief summary

Patients practicing Tai Chi will exhibit significant improvements in primary outcome measures of balance, and secondary outcomes of gait, physical performance, Unified Parkinson's Disease Rating Scale, Falls, muscle strength.

Detailed description

The study is designed to determine the effects of Tai Chi training on balance and other functional outcomes in persons with Parkinson's disease.

Interventions

BEHAVIORALTai Chi

a set of pre-designed Tai Chi Movements

BEHAVIORALStrength training

Lower-extremity strength training exercises

BEHAVIORALLow-Impact Exercise Control

a set of chair-based low-impact exercises

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS)
CollaboratorNIH
Oregon Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

Patients who have: * A diagnosis of idiopathic PD, with a disease severity rating of stage I to IV on the Hoehn and Yahr scale (Hoehn & Yahr, 1967) * At least 1 score of 2 or more for at least 1 limb for either the tremor, rigidity, or bradykinesia item of the Unified Parkinson's Disease Rating Scale (UPDRS) * Stable medication usage * Not participated in a structured exercise program (i.e., not involved in any routine, organized physical activity program lasting 30 minutes or more per day, such as a gym program or regularly scheduled instructor-led exercise class) in the previous 2 months * Ability to stand unaided or walk independently; had a personal physician's or neurologist's clearance for participation; and had a willingness to be assigned to intervention conditions.

Exclusion criteria

Patients who: * Participate in any other behavioral or pharmacological research study * Have cognitive decline (Mini-Mental State Examination score, ≤ 24) (Folstein et al., 1975) * Have self-reported diagnosis of Alzheimer disease or other severe neurological (stage III and IV PD) * Have evidence of progressive or debilitating conditions (metastatic cancer, severe heart or lung disease, crippling arthritis) or severe losses in vision and hearing that would limit their tolerance to testing and training procedures, that would interfere with study participation * Are unavailable during the study period.

Design outcomes

Primary

MeasureTime frame
Balance3 time points

Secondary

MeasureTime frame
gait, physical performance, Unified Parkinson's Disease Rating Scale, falls, Muscle strength3 time points

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026